Literature DB >> 17294286

The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety.

Alison L Supina1, Jeffrey A Johnson, Scott B Patten, Jeanne V A Williams, Colleen J Maxwell.   

Abstract

BACKGROUND: Major depressive episodes (MDE) and anxiety disorders are associated with significantly lower health-related quality of life (HRQL). The present study explores the ability of the EQ-5D HRQL measure to differentiate among those with a clinical diagnosis of MDE and/or anxiety disorders.
METHODS: Data were collected as part of the Alberta Mental Health Survey (2003). MDE and anxiety were defined by DSM-IV using the Mini International Neuropsychiatric Interview (M.I.N.I). Descriptive and multivariate regression analyses were used to examine associations between EQ-5D scores and mental health diagnoses.
RESULTS: The prevalence for diagnoses (and proportion within each group reporting problems on the Anxiety/Depression domain) were: MDE alone 2.6% (48.6%); anxiety disorders alone 11.2% (38.9%); MDE and anxiety 5.2% (81.1%); and neither 80.9% (8.2%), respectively. Adjusted mean EQ-Index and EQ-VAS scores were shown to be significantly lower among those with MDE and anxiety disorders (0.70, 64.2), followed by those with MDE alone (0.83, 70.8) and anxiety disorders alone (0.84, 76.7), when compared with subjects with none of these conditions.
CONCLUSIONS: Reporting problems on the EQ-5D Anxiety/Depression domain was more common among subjects with MDE alone than anxiety disorders alone. Other domains of the EQ-5D did identify the burden of co-morbid mental health conditions, but not as well as the Anxiety/Depression domain.

Entities:  

Mesh:

Year:  2007        PMID: 17294286     DOI: 10.1007/s11136-006-9159-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  17 in total

1.  Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.

Authors:  Paul Dolan; Jennifer Roberts
Journal:  Med Care       Date:  2002-05       Impact factor: 2.983

2.  Preliminary longitudinal assessment of quality of life in patients with major depression.

Authors:  J M Pyne; T L Patterson; R M Kaplan; S Ho; J C Gillin; S Golshan; I Grant
Journal:  Psychopharmacol Bull       Date:  1997

3.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

4.  Associations of self-reported anxiety symptoms with health-related quality of life and health behaviors.

Authors:  Tara W Strine; Daniel P Chapman; Rosemarie Kobau; Lina Balluz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

5.  [Use of a structured diagnostic interview to identify depressive episodes in an epidemiologic study: a posteriori internal validation].

Authors:  A Duburcq; P Blin; Y Charpak; C Blachier; M P Allicar; M Bouhassira; T Hergueta; Y Lecrubier
Journal:  Rev Epidemiol Sante Publique       Date:  1999-10       Impact factor: 1.019

6.  Assessment of the quality of life of patients with major depression.

Authors:  J M Pyne; T L Patterson; R M Kaplan; J C Gillin; W L Koch; I Grant
Journal:  Psychiatr Serv       Date:  1997-02       Impact factor: 3.084

7.  Can gender differences in the prevalence of mental disorders be explained by sociodemographic factors?

Authors:  M Klose; F Jacobi
Journal:  Arch Womens Ment Health       Date:  2004-03-22       Impact factor: 3.633

Review 8.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

9.  Psychiatry and the burden of mental illness.

Authors:  R C Bland
Journal:  Can J Psychiatry       Date:  1998-10       Impact factor: 4.356

10.  Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder.

Authors:  Christophe Sapin; Bruno Fantino; Marie-Laure Nowicki; Paul Kind
Journal:  Health Qual Life Outcomes       Date:  2004-05-05       Impact factor: 3.186

View more
  15 in total

Review 1.  Quality of life in panic disorder: looking beyond symptom remission.

Authors:  Julia Davidoff; Scott Christensen; David N Khalili; Jaidyn Nguyen; Waguih William IsHak
Journal:  Qual Life Res       Date:  2011-09-21       Impact factor: 4.147

2.  Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.

Authors:  Katelynn Crick; Fatima Al Sayah; Arto Ohinmaa; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2018-03-07       Impact factor: 4.147

3.  EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada.

Authors:  Kate Tsiplova; Eleanor Pullenayegum; Tim Cooke; Feng Xie
Journal:  Qual Life Res       Date:  2016-06-15       Impact factor: 4.147

4.  Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).

Authors:  Alessandra Barraco; Andrea Rossi; Giuseppe Nicolò
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

5.  Diet quality and feelings of worry, sadness or unhappiness in Canadian children.

Authors:  Seanna E McMartin; Noreen D Willows; Ian Colman; Arto Ohinmaa; Kate Storey; Paul J Veugelers
Journal:  Can J Public Health       Date:  2013-07-25

6.  Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders.

Authors:  Hans-Helmut König; Anja Born; Oliver Günther; Herbert Matschinger; Sven Heinrich; Steffi G Riedel-Heller; Matthias C Angermeyer; Christiane Roick
Journal:  Health Qual Life Outcomes       Date:  2010-05-05       Impact factor: 3.186

7.  Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.

Authors:  Hans-Helmut König; Oliver H Günther; Matthias C Angermeyer; Christiane Roick
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care.

Authors:  Esther Muskens; Rhona Eveleigh; Peter Lucassen; Chris van Weel; Jan Spijker; Peter Verhaak; Anne Speckens; Richard Oude Voshaar
Journal:  BMC Fam Pract       Date:  2013-01-08       Impact factor: 2.497

9.  Health-related quality of life as measured with EQ-5D among populations with and without specific chronic conditions: a population-based survey in Shaanxi Province, China.

Authors:  Zhijun Tan; Ying Liang; Siming Liu; Wenjun Cao; Haibo Tu; Lingxia Guo; Yongyong Xu
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Correspondence between EQ-5D health state classifications and EQ VAS scores.

Authors:  David K Whynes
Journal:  Health Qual Life Outcomes       Date:  2008-11-07       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.